INTRODUCTION
Stroke is a leading global cause of disability [
1]. Neurological disorders like stroke can impair body functions most often movement [
2]. Many stroke patients experience difficulties carrying out activities of daily living. They undergo rehabilitative therapies to improve their motor function. However, the impairment in movement is not fully recovered in many cases, and stroke patients live with the stroke-related disabilities [
1]. With the aim for improving motor function after stroke and minimizing disabilities, various rehabilitative therapies have been developed [
3].
The balance impairment in patients with hemiplegia after stroke is usually caused by loss of muscle strength and coordination, spasticity, neurological disorders or degenerative disorder [
4]. The risk for falls increases, and activities of daily living functioning is affected as a result. Falling accidents can cause serious results, such as fracture and traumatic brain damage [
5]. Pelvic fracture is the most common injury caused by falls, and it take a great amount of time to recover when it occurs in elderly people [
6].
Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation approach that is increasingly generated interest [
7] as a means increasing or decreasing cortical excitability, depending on the delivery of anodal or cathodal stimulation to the cerebral cortex.
Many studies have focused on the effects of tDCS of the cerebral cortex on upper limb function. Nitsche and Paulus [
8] reported the temporary increase and decrease of the cortical excitability in response to tDCS anodal or cathodal stimulation, respectively, delivered to the upper limb area of the primary motor cortex. Hummel et al. [
9] reported improved activities of daily living including hand movements in stroke survivors when the upper limb area of the motor cortex was stimulated by tDCS in addition to palliative rehabilitative intervention. Kim et al. [
10] reported tDCS was effective in improving the function of the hemiplegic side of the affected upper limb and that this improved function continued after stimulation.
Stroke can also lead to gait disability by affecting lower limb movement and function as it does to the upper limb. Studies that investigated effects of tDCS on lower limb function have been more recent. In 2007, Jeffery et al. [
11] reported an increase in the amplitude of motor evoked potential (MEP) in the tibialis anterior muscle after tDCS on the leg area of primary motor cortex. In 2009, Tanaka et al. [
12] claimed that the muscle strength of toes on the contralateral side improved temporarily as anodal tDCS was administered to the leg area of the primary motor cortex in healthy adults. In 2011, the same authors reported a statistically significant improvement in knee extensor strength in the hemiplegic side when anodal tDCS was delivered on the ipsilesional leg area of the primary motor cortex via tDCS in chronic stroke patients [
13].
Studies related to tDCS have concentrated on upper limb function rather than lower limb. Still, no study has investigated effects of tDCS on balance. We investigated effects of tDCS on the leg motor function measured by balance performance, posture control function and knee extensor strength by applying anodal stimulation on the leg area of the primary motor cortex in subacute stroke patients with hemiplegia.
DISCUSSION
This study investigated the effects of anodal tDCS administered to the leg area of the primary motor cortex on the lower limb muscle strength and balance performance in stroke patients with hemiplegia. The study was designed with the assumption that impaired leg strength resulting from the hemiplegia would affect balance performance. This means that improved muscle strength of the leg by anodal tDCS would increase balance performance significantly. Tomas-Carus et al. [
19] suggested a correlation between knee extensor strength and balance in patients with fibromyalgia. Tanaka et al. [
12] claimed that improvement in contralateral side of lower limb muscle strength was elicited by anodal tDCS. Effects of anodal tDCS has been proven in stroke patients with hemiplegia as their lower limb movement control improved after anodal tDCS to the leg primary motor cortex on the affected side [
16].
This study also found a significant increase in knee extensor peak torque after anodal tDCS on the leg area of the affected primary motor cortex, when compared with baseline measurement. Also, in the overall stability index, in which an increased score means a poor balance performance, also significantly decreased after the anodal tDCS. Thus, the results of this study support the hypothesis that tDCS of the leg area of the primary motor cortex on the affected side boosts lower limb muscle strength, which also leads to benefits in balance performance.
The results are consistent with those of earlier studies in anodal tDCS delivered to the hand or leg area of the primary motor cortex. Hummel et al. [
9] and Fregni et al. [
20] reported improved upper limb function after administering tDCS to the M1 area of the cerebral cortex on the affected area for 20 minutes in stroke patients. Although the recovery of walking ability is the most important goal for stroke patients [
21], studies investigating non-invasive brain stimulations as a supplementary approach in improving lower limb function have only recently been carried out. Tanaka et al. [
13] reported increased knee extensor strength after anodal tDCS on the lower leg area of the primary motor cortex on the affected area in chronic stroke patients with hemiplegia. But, the effects of sham stimulation were not significant. In this study, effects of tDCS on balance performance were also found.
Previous studies have used functional MRI (fMRI) to assess changes resulting from hand and finger movement. In one study, anodal tDCS increased activation of the ipsilateral supplementary motor area and lowered the extent of activation of both anterior cingulated gyri, right middle and superior temporal gyri, middle and superior frontal gyri, and primary and secondary somatosensory cortices [
22]. The authors reported that anodal tDCS modulated the activity of the leg motor cortex in healthy subjects, which supports the present results.
In a previous study, tDCS used to facilitating upper limb function was administered at 1 mA, lower than the 2 mA used in this study. Jeffery et al. [
11] found in a preliminary study that anodal stimulation delivered at the intensity of 1 mA failed to affect lower limb MEPs. This finding was likely due to the fact that the leg area of primary motor cortex is located further inside the motor cortex than the arm area. Any anodal stimulation administered at a level of 2 mA improves the amplitude of leg MEPs, which is similar to a 40% increase in the improvement achieved in amplitude of hand MEPs at a level of 1 mA. This study also administered anodal tDCS at an intensity of 2 mA to accelerate the stimulation to the leg area of the primary motor cortex.
The correlation between pre-tDCS knee extensor peak torque and balance performance was not statistically significant. Factors that affect balance performance are strength, cerebellar function, visual acuity, proprioception, inner ear function, foot position on the ground, leg length discrepancy, medication, age, heartbeat, respiration, and auditory function. Further studies should include evaluations for all factors affecting balance performance, whether these factors would be affected by tDCS or not.
This study has some limitations. First, the number of subjects was too small to ensure statistical verification. Second, a double-blind design was not used for experiments. Third, the stimulation was intended for the primary motor cortex. But, given the nature of tDCS, the actual stimulation site extended beyond the primary motor cortex. It is therefore hard to estimate whether obtained improvement was elicited solely by a change in the primary motor cortex or whether other areas of the cerebral cortex also contributed to the improvement. Further study needs to include neuroimaging analysis. Fourth, despite improvement in muscle strength and balance performance in the hemiplegic side, the association between muscle strength and balance performance could not be clearly identified because of the lack of electrophysiological index, such as MEP, on the affected side of the lesion. Fifth, we included patients with either cerebral hemorrhage or cerebral infarction. So, we could not explain the different effects of tDCS on balance between cerebral hemorrhagic lesion and cerebral infarction lesion.
Despite limitations, this study is distinguished from previous studies by proving effects of tDCS on balance performance, which is a crucial element in walking ability and preventing falls. Given that walking ability is the most desired treatment outcome for many patients, previous studies examined excitability of the cerebral cortex, lower limb movement and muscle strength as beneficial areas of tDCS. The use of tDCS as a supplementary application in addition to rehabilitation in stroke patients is expected to optimize treatment outcomes.
In conclusion, this study observed the improvement in isometric knee extensor strength and balance performance after anodal tDCS of the primary motor cortex on the affected side of the lesion in subacute stroke patients with hemiplegia who can walk. Anodal tDCS administered to the primary motor cortex may be an effective supplementary choice for improving lower limb muscle strength and balance performance in stroke patients seeking rehabilitation.